Atıf Formatları
Clinical significance of Ezrin and Neuropilin-2 expression in advanced renal cell carcinoma
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. E. ÇETİN Et Al. , "Clinical significance of Ezrin and Neuropilin-2 expression in advanced renal cell carcinoma," European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands, 2013

ÇETİN, B. E. Et Al. 2013. Clinical significance of Ezrin and Neuropilin-2 expression in advanced renal cell carcinoma. European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , (Amsterdam, Netherlands).

ÇETİN, B. E., IŞIK GÖNÜL, İ., Buyukberber, S., Afsar, B., Gumusay, Ö., Benekli, M., ... COŞKUN, U.(2013). Clinical significance of Ezrin and Neuropilin-2 expression in advanced renal cell carcinoma . European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands

ÇETİN, BEKİR Et Al. "Clinical significance of Ezrin and Neuropilin-2 expression in advanced renal cell carcinoma," European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 2013

ÇETİN, BEKİR E. Et Al. "Clinical significance of Ezrin and Neuropilin-2 expression in advanced renal cell carcinoma." European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands, 2013

ÇETİN, B. E. Et Al. (2013) . "Clinical significance of Ezrin and Neuropilin-2 expression in advanced renal cell carcinoma." European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands.

@conferencepaper{conferencepaper, author={BEKİR EREN ÇETİN Et Al. }, title={Clinical significance of Ezrin and Neuropilin-2 expression in advanced renal cell carcinoma}, congress name={European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO}, city={Amsterdam}, country={Netherlands}, year={2013}}